YBX1 and metabolic dysfunction-associated steatotic liver disease: In conclusion, our study demonstrates that YB1 knockdown promotes NAFLD cell viability, suppresses lipid metabolism, and reduces ROS and MDA levels, likely through modulation of the TGF-β signaling pathway.